Respiratory center disorders are frequent causes of periodic apnea, and assessing ventilatory responses to hypoxemia and hypercarbia has become clinically important. Hypoxic and hypercarbic challenges can be executed in a hospital pulmonary function laboratory. In hypoxic challenge the patient breathes from a spirometer with an initial FO2 of 0.30. Helium replaces the oxygen used by the patient and the test is terminated if system FO₂ drops to 0.06, if the patient's blood oxygen saturation drops to 70%, or if minute ventilation triples. In hypercarbic challenge the patient breathes from a spirometer with no carbon dioxide absorber. System FO2 of 0.50 is maintained and F CO2 is monitored. The test is terminated if the patient experiences hypercarbia, if the FECO2 increases 3%, or if minute ventilation triples. Combined hypoxic-hypercarbic challenge is used to determine central depression secondary to hypoxemia in patients with intact responses to hypercarbia. In this test the patient breathes from a spirome-ter with no carbon dioxide absorber and an initial system Fo₂ of 0.30 is used. Helium is bled into the spirometer to replace oxygen used. Criteria for termination of the test are the sum of those used for hypoxic and hypercarbic challenges. In a patient with diabetic neuropathies and nephropathy who was experiencing periodic apnea, hypoxic and hypercarbic challenges revealed absent response to hypoxemia but rela-tively normal response to hypercarbia. Oxygen cannula therapy at 5 1/min was initiated to prevent central depression and eliminated the apneic spells for five months following treatment.